Effects of propiverine and naftopidil on the urinary ATP level and bladder activity after bladder stimulation in rats

Neuroscience Letters

Volumn 429, Issue 2-3, 2007, Pages 142-146

  Sugaya, Kimio ^a   Nishijima, Saori ^a   Tasaki, Shinsuke ^a   Kadekawa, Katsumi ^a   Miyazato, Minoru ^a   Ogawa, Yoshihide ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Alpha 1 blocker; Anticholinergic agent; Bladder activity; Urinary ATP

Indexed keywords

ACETIC ACID; ADENOSINE TRIPHOSPHATE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; NAFTOPIDIL; PROPIVERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CONTRACTION; BLADDER EPITHELIUM; BLADDER PRESSURE; CONTROLLED STUDY; CYSTOMETRY; DRUG MEGADOSE; FEMALE; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; RAT; URINALYSIS; URINARY FREQUENCY; UROTHELIUM;

ACETIC ACID; ADENOSINE TRIPHOSPHATE; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BENZILATES; CHOLINERGIC ANTAGONISTS; DRUG INTERACTIONS; ENERGY METABOLISM; FEMALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NAPHTHALENES; PIPERAZINES; PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, MUSCARINIC; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; UROTHELIUM;

EID: 36348946817     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.10.003     Document Type: Article

References (30)

1. Andersson K.E. Bladder activation: afferent mechanisms. Urology 59 (2002) 43-50
2. Andersson K.E., and Yoshida M. Antimuscarinics and the overactive detrusor: which is the main mechanism of action?. Eur. Urol. 43 (2006) 1-5
3. Athanasopoulos A., Gyftopoulos K., Giannitsas K., Fisfis J., Perimenis P., and Barbalias G. Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study. J. Urol. 169 (2003) 2253-2256
4. Beckel J.M., Barrick S.R., Keast J.R., Meyers S.A., Kanai A.J., de Groat W.C., Zeidel M.L., and Birder L.A. Expression and function of urothelial muscarinic receptors and interactions with bladder nerves. Soc. Neurosci. 846 (2004) 23 (Abstract viewer)
5. Birder L.A., Nakamura Y., Kiss S., Nealen M.L., Barrick S., Kanai A.J., Wang E., Ruiz G., de Groat W.C., Apodaca G., Watkins S., and Caterina M.J. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat. Neurosci. 5 (2002) 856-860
6. Birder L.A., Barrick S.R., Roppolo J.R., Kanai A.J., de Groat W.C., Kiss S., and Buffington C.A. Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium. Am. J. Physiol. Renal Physiol. 285 (2003) 423-429
7. Birder L.A., Ruan H.Z., Chopra B., Xiang Z., Barrick S., Buffington C.A., Roppolo J.R., Ford A.P., de Groat W.C., and Burnstock G. Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am. J. Physiol. Renal Physiol. 287 (2004) F1084-F1891
8. Chapple C.R. Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician. BJU Int. 94 (2004) 738-744
9. de Groat W.C. The urothelium in overactive bladder: passive bystander or active participant?. Urology 64 (2004) 7-11
10. Ferguson D.R., Kennedy I., and Burton T.J. ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes-a possible sensory mechanism?. J. Physiol. 505 (1997) 503-511
11. Ferguson D.R. Urothelial function. BJU Int. 84 (1999) 235-242
12. Ishihama H., Momota Y., Yanase H., Wang X., de Groat W.C., and Kawatani M. Activation of alpha1D adrenergic receptors in the rat urothelium facilitates the micturition reflex. J. Urol. 175 (2006) 358-364
13. Kenny B., Ballard S., Blagg J., and Fox D. Pharmacological options in the treatment of benign prostatic hyperplasia. J. Med. Chem. 40 (1997) 1293-1315
14. Khera M., Somogyi G.T., Kiss S., Boone T.B., and Smith C.P. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem. Int. 45 (2004) 987-993
15. Nakajima M.O., Etoh Y., Yanai M., Kawamura R., Kaneko K., Aoyagi K., and Koiso K. Novel renal function marker, ATP-establishing the normal range, cases of anti-tumor drags administration for urinary-track tumor, diabetic diseases and a newborn baby. Rinsho Byori 50 (2002) 513-518
16. Nishijima S., Sugaya K., Miyazato M., and Ogawa Y. Effect of Gosha-jinki-gan, a blended herbal medicine, on bladder activity in rats. J. Urol. 177 (2007) 762-765
17. Proskocil B.J., Sekhon S.S., Jia Y., Savchenko V., Blakley R.D., Lindstron J., and Spindel E.R. Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology 145 (2004) 2498-2506
18. Salas N.A., Somogyi G.T., Gangitano D.A., Boone T.B., and Smith C.P. Receptor activated bladder and spinal ATP release in neurally intact and chronic spinal cord injured rats. Neurochem. Int. 50 (2007) 250-345
19. Stohrer M., Murtz G., Kramer G., Schnabel F., Arnold E.P., and Wyndaele J.J. Propiverine investigator group. Propiverine compared to oxybutynin in neurogenic detrusor overactivity-results of a randomized, double-blind, multicenter clinical study. Eur. Urol. 51 (2007) 235-242
20. Sugaya K., Nishijima S., Miyazato M., Ashitomi K., Hatano T., and Ogawa Y. Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats. Neurosci. Lett. 328 (2002) 74-76
21. Takahashi S., Tajima A., Matsushima H., Kawamura T., Tominaga T., and Kitamura T. Clinical efficacy of an alpha1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia. Int. J. Urol. 13 (2006) 15-20
22. Tata A.M., Tripiciano A., Filippini A., Biagioni S., and Augusti-Tocco G. Muscarinic receptors modulate intracellular calcium level in chick sensory neurons. Brain Res. 866 (2000) 65-72
23. Tokuno H., Chowdhury J.U., and Tomita T. Inhibitory effects of propiverine on rat and guinea-pig urinary bladder muscle. Naunyn Schmiedebergs Arch. Pharmacol. 348 (1993) 659-662
24. Uehara Y., Yanai M., and Kumasaka K. Evaluation of renal damage using urinary ATP analysis. Nippoin Jinzo Gakki Shi 46 (2004) 693-699
25. Vizi E.S., Liang S.D., Sperlagh B., Kittel A., and Juranyi Z. Studies on the release and extracellular metabolism of endogenous ATP in rat superior cervical ganglion: support for neurotransmitter role of ATP. Neuroscience 79 (1997) 893-903
26. Wang X., Kawatani M., Momota Y., Yanase H., and Nimura T. Noradrenalin evokes ATP release in the bladder lumen and promotes micturition reflex. J. Physiol. Soc. Jpn. 69 (2007) 36-37
27. Yamada S., Suzuki M., Tanaka C., Mori R., Kimura R., Inagaki O., Honda K., Asano M., Takenaka T., and Kawabe K. Comparative study on alpha 1-adrenoceptor antagonist binding in human prostate and aorta. Clin. Exp. Pharmacol. Physiol. 21 (1994) 405-411
28. Yoshida M., Inadome A., Murakami S., Miyamae K., Iwashita H., and Otani M. Effects of age and muscle stretching on acetylcholine release in isolated human bladder smooth muscle. J. Urol. 167 (2002) 40 (Abstract)
29. Yoshida M., Miyamae K., Iwasguta H., Otani M., and Inadome A. Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology 63 (2004) 17-23
30. Zhang X., Ishizuka O., Tanabe T., Satoh T., Nakayama T., Imamura T., and Nishizawa O. Effects of goshajinkigan (niu-che-sen-qi-wan) for resiniferatoxin-sensitive afferents on detrusor overactivity induced by acetic acid in conscious rats. Am. J. Chin. Med. 34 (2006) 285-293